Relugolix and QT/QTc Interval Prolongation

In this article, we will discuss Relugolix and QT/QTc Interval Prolongation. So, let’s get started.

Relugolix and QT/QTc Interval Prolongation

Androgen deprivation therapy, such as relugolix may prolong the QT/QTc interval. Providers should consider whether the benefits of androgen deprivation therapy outweigh the potential risks in patients with congenital long QT syndrome, congestive heart failure, or frequent electrolyte abnormalities and in patients taking drugs known to prolong the QT interval. Electrolyte abnormalities should be corrected. Consider periodic monitoring of electrocardiograms and electrolytes.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.